LeonaBio, Inc. Increase (Decrease) in Other Noncurrent Liabilities
LeonaBio, Inc. (LONA) reported Increase (Decrease) in Other Noncurrent Liabilities of -$370.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-14
- LeonaBio, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was -$187.00K.
- LeonaBio, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was -$183.00K.
- LeonaBio, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was -$59.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|
| 2026-06-30 | -$187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$370.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$183.00K 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | -$59.00K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |